• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

CPTH2 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5759149

MBS5759149 is an inhibitor targeting CPTH2. CPTH2 is a histone acetyltransferase inhibitor modulating Gcn5 network. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
CPTH2, Inhibitor
Full Product Name
CPTH2
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
99.50%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
291.80
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C14H14ClN3S
SMILES
Clc1ccc(cc1)-c1csc(N\N=C2\CCCC2)n1
CAS Number
357649-93-5
Target & IC50
Histone Acetyltransferase inhibitor
In Vitro
CPTH2 decreases cell viability, adhesion, and invasiveness in ccRCC cell line 786-O. It shows preferential inhibition for KAT3B-p300 with hypoacetilating effects on histone H3 at specific H3-K18. Immunohistochemical analysis of 70 ccRCC tumor tissues compared with peritumoral normal epithelium showed a statistical significant reduction of p300/H3AcK18 paralleled by an increase of H3AcK14 in G1 grade and an opposed trend during tumor progression to worst grades[1].

Product Categories/Family for CPTH2, inhibitor

Structure of CPTH2, inhibitor

CPTH2 Inhibitor – Cat# MBS5759149

Product References and Citations for CPTH2, inhibitor

Cocco E, et al. KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumoraggressiveness and target of KAT inhibitor CPTH Clin Epigenetics. 2018 Apr 4;10:44.
Cocco E, et al. KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumoraggressiveness and target of KAT inhibitor CPTH2. Clin Epigenetics. 2018 Apr 4;10:44.
Thevis M, Schaenzer W. Emerging drugs affecting skeletal muscle function and mitochondrial biogenesis - Potential implications for sports drug testing programs[J]. Rapid Communications in Mass Spectrometry, 2016, 30(5):635-651.
Thevis M, Schaenzer W. Emerging drugs affecting skeletal muscle function and mitochondrial biogenesis - Potential implications for sports drug testing programs[J]. Rapid Communications in Mass Spectrometry, 2016, 30(5):635-651.

Other Notes

Small volumes of CPTH2, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000